Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBritish American Tobacco Regulatory News (BATS)

Share Price Information for British American Tobacco (BATS)

Share Price is delayed by 15 minutes
Get Live Data
4,497.00    -114.00 (-2.47%)
Bid:
4,505.00
Ask:
4,506.00
Spread: 1.00 (0.022%)
Market Cap: £97.08b
BATS Live PriceLast checked at - London Stock Exchange

Intraday British American Tobacco Share Chart

Directorate Change

4 Dec 2023 09:24

RNS Number : 5493V
British American Tobacco PLC
04 December 2023
 

British American Tobacco p.l.c.

 

4 December 2023 

 

 

Directorate Change

Serpil Timuray joins the Board of British American Tobacco p.l.c. as an independent Non-Executive Director with effect from 4 December 2023 and as a member of the Nominations and Remuneration Committees.

Serpil is currently the CEO of Europe Cluster and a member of the Executive Committee at Vodafone Group. She joined Vodafone in 2009 and has held a variety of executive roles being the Group Chief Commercial Operations and Strategy Officer in charge of areas including global strategy, marketing, innovation and digital transformation, the Regional CEO for AMAP (Africa, Middle East, Asia, Pacific), and the CEO of Turkey. Prior to joining Vodafone, Serpil was the CEO of Danone Dairy Turkey, having started her career in 1991 at Procter & Gamble where she held several marketing roles. Serpil is currently Non-Executive Director of TPG Telecom Plc. She previously served as an independent Non-Executive Director of Danone Group Plc from 2015 to 2023 and as the Chair of the Corporate Social Responsibility Committee.

Commenting on the appointment, Luc Jobin, Chair of the Board, said: "I am pleased to welcome Serpil Timuray to our board. Her extensive experience in growing consumer and enterprise product companies in technology and fast-moving consumer goods sectors, and in managing global strategy, innovation and digital transformation will be beneficial to the Board as we continue to accelerate our strategy to build A Better Tomorrow".

Enquiries:

British American Tobacco Press Office+44 (0) 20 7845 2888 (24 hours) | @BATPress 

 

British American Tobacco Investor RelationsVictoria Buxton/Amy Chamberlain/ Yetunde Ibe/John Harney/Jane Henderson+44 20 7845 2012/1124/1095/1263/1117

 

Additional information

1. This announcement is made in compliance with the Company's obligations under Listing Rule 9.6.11.

2. In accordance with the Listing Rules, Serpil Timuray is Non-Executive Director of TPG TELECOM Plc and was previously a director of Danone Group plc. There are no additional matters that would require disclosure under 9.6.13R of the Listing Rules of the UK Financial Conduct Authority in respect of his appointment.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUPGQCPUPWURC
Date   Source Headline
5th Mar 202612:30 pmRNSDirector/PDMR Shareholding
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20261:50 pmRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 202611:00 amRNSBAT to Present at CAGNY; Reaffirming FY26 Guidance
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20265:00 pmRNSDirector/PDMR Shareholding
17th Feb 202612:30 pmRNSDirector/PDMR Shareholding
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20266:00 pmRNSDirector/PDMR Shareholding
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20262:00 pmRNSAnnual Financial Report
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:30 amRNSShare Buyback Programme
12th Feb 20267:05 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSPreliminary Results
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20269:00 amRNSBoard Update - Chair Extension and SID Appointment
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20263:00 pmRNSHolding(s) in Company
9th Feb 202611:00 amRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 202611:10 amRNSDirector/PDMR Shareholding
6th Feb 202611:05 amRNSDirector/PDMR Shareholding
6th Feb 202611:00 amRNSDirector/PDMR Shareholding
6th Feb 202610:45 amRNSDirector/PDMR Shareholding
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 202612:15 pmRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20264:30 pmRNSHolding(s) in Company
26th Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.